Efficacy and risk of isolated distal thrombosis anticoagulation: a multicenter prospective case-control study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300076368

Enrollment

Unknown

Registered

2023-10-07

Start date

2023-10-08

Completion date

Unknown

Last updated

2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep vein thrombosis

Interventions

Anticoagulation group and no anticoagulation group:none

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: compatible with the diagnosis of isolated distal thrombosis: isolated distal thrombosis (IDDVT) is defined as a limitation of the distal or lower leg thrombosis (DVT) below the popliteal vein of the lower extremity, there was no concomitant proximal DVT (PDVT) or pulmonary embolism (PE) .

Exclusion criteria

Exclusion criteria: active bleeding, previous thrombosis or thrombosis, previous abnormalities in coagulation and fibrinolysis, active cancer, severe liver and renal insufficiency, and cannot cooperate with follow-up and other research steps.

Design outcomes

Primary

Measure	Time frame
death;hemorrhage;VTE recurrence;	—

Countries

China

Contacts

Public ContactFeng Liang

Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou,

fenglcm168@163.com+86 137 5716 8389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026